(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AMNOL CHIMICA BIOLOGICA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

AMNOL CHIMICA BIOLOGICA

ST13

US500000079215411

Class

5

Filing

79215411

Registration

5499921

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

03/06/2026

Trademark type

Combined

Nice classes

5

Filing date

05/04/2017

Registration date

06/26/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/10/2025

Last transaction

03/06/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

3

Owner type

16

Owner location

IT

Examiner

NADELMAN, ANDREA KOYNER

Law office

M10

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "AMNOL CHIMICA BIOLOGICA" inside an incomplete oval border that has two vertical bars extending inside the oval above and below the letter "M" in "AMNOL".

Holders and representatives

Holders

Ceres Pharma Italy S.R.L.
AMNOL CHIMICA BIOLOGICA S.r.l.

Representatives

John Zaccaria Notaro, Michalos & Zaccaria P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment and prevention of dermatologicalcardiovascularhaematologicalbonerespiratorycentral nervous systemendocrinologicalcirculatorygastroenterologicalstomachdigestivehormonaldiabeticmuscularrheumaticimmune systemocular and metabolic diseases and disorders; pharmaceuticals to treat and prevent diabetescoughscoldsinfluenzaheadaches and allergic reactions; anti-infectives; anti-inflammatories; vaccines; dietetic substances for medical purposesnutritionalvitamin and mineral supplements and preparations; dietetic food and substances for use in treating and preventing of dermatologicalcardiovascularhaematologicalbonerespiratorycentral nervous systemendocrinologicalcirculatorygastroenterologicalstomachdigestivehormonaldiabeticmuscularrheumaticimmune systemocular and metabolic diseases and disorders for medical use; food for babies; dietary supplements for humans and animals

Publications

History of USPTO decisions and trademark events.

31 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

03/05/2026

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

02/18/2026

INPC

INVALIDATION PROCESSED

02/17/2026

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

09/10/2025

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

08/28/2025

C71T

CANCELLED SECTION 71

01/10/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

06/26/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/18/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/19/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/29/2018

FIMP

FINAL DISPOSITION PROCESSED

09/29/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/26/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

06/26/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/10/2018

PUBO

PUBLISHED FOR OPPOSITION

04/10/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/21/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/06/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/06/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/05/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/05/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/05/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/05/2018

RFNT

REFUSAL PROCESSED BY IB

09/30/2017

MAFR

APPLICATION FILING RECEIPT MAILED

09/12/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/11/2017

RFRR

REFUSAL PROCESSED BY MPU

09/11/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/09/2017

CNRT

NON-FINAL ACTION WRITTEN

09/08/2017

DOCK

ASSIGNED TO EXAMINER

09/06/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/06/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/31/2017

Continuous trademark protection

Get notified about every new filing that threatens AMNOL CHIMICA BIOLOGICA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.